VERO Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Key facts about Vero cells
| Description | VERO cells are widely used in developing vaccines, in the study of viral infections or malaria, and in tumor immunology and immunotherapy studies. VERO cells were derived from the kidney of an African green monkey in the 1960s by a group of Japanese scientists at Chiba University in Japan. One of the critical characteristics of VERO cells is their rapid growth rate, with a population doubling time of approximately 24 hours. This, combined with their stability and high viral titers, makes them an ideal choice for vaccine production. As a prominent example, a Vero cell-derived vaccine for Japanese encephalitis is widely used and licensed in many countries worldwide. Vero cells were pivotal in the development of vaccines for a plethora of infectious diseases, including the rubella virus, Ross River virus, herpes simplex virus, measles virus, and poliovirus. Vero cells are renowned for their capacity for virus production, growth, and maintenance under optimized culture conditions, making them an invaluable resource in viral vaccine production. The role of Vero cells extends to the generation of viral vectors, crucial for both vaccine development and tissue engineering applications, and virus isolation. Different VERO cell lines, such as Vero 76 and the subclone Vero E6, offer unique characteristics suited to various research and production needs. Vero 76 cells are known for their robust growth and are widely used in vaccine production due to their high virus yield capabilities. Vero E6, on the other hand, exhibits specific properties that make it particularly useful for studying certain viruses, including enhanced sensitivity to the Ebola virus and SARS-CoV-2. This subclone's unique interaction with viruses makes it valuable for viral pathogenesis studies and antiviral drug screening. |
|---|---|
| Organism | Chlorocebus sabaeus (Green monkey) |
| Tissue | Kidney |
| Applications | Transfection host |
| Synonyms | Vero, VeroCCL81, Vero 81, Verda reno |
Details of the Vero cell line
| Age | Adult |
|---|---|
| Gender | Female |
| Morphology | Epithelial-like |
| Growth properties | Monolayer, adherent |
Features
| Citation | VERO (Cytion catalog number 605372) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 60711 |
| CellosaurusAccession | CVCL_0059 |
Specifications of Vero cells
| Receptors expressed | Despite not being interferon deficient, VERO cell line possesses the interferon-alpha/beta receptor, allowing them to respond normally when recombinant interferon is added to their culture medium. |
|---|---|
| Viruses | Verotoxin detection of virus in ground beef |
| Virus susceptibility | Poliovirus 1, 2, 3, Getah, Ndumu, Pixuna, Ross River, Semliki Forest, Paramaribo, Kokobera, Modoc, Murutucu, Germiston, Guaroa, Pongola, Tacaribe, SV-5, SV40, rubeola, rubellavirus, reovirus 1, 2, 3, simian adenoviruses |
| Reverse transcriptase | Negative |
| Mutational profile | Vero cells have a homozygous 9-Mb deletion on chromosome 12 that results in loss of the type I interferon gene cluster and the cyclin-dependent kinase inhibitors CDKN2A and CDKN2B. |
Handling the Vero cell line
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality control
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 605372-250822 | Certificate of Analysis | 22. Jan. 2026 | 605372 |
-
Required products
Required products
Antibiotic/Antimycotic Solution (100x)Product Overview
Volume: 100 ml
Storage: ≤-15°C
Sterility: Sterile-filtered
Antibiotic/Antimycotic Solution (100x) is a sterile, ready-to-use concentrate designed to reduce microbial contamination risks in cell culture and related laboratory applications. This 100x solution contains a well-established combination of penicillin, streptomycin, and amphotericin B—providing broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria, yeasts, and filamentous fungi. The formulation is suitable for use in eukaryotic cell cultures, bacterial media, and other contamination-sensitive systems, supporting clean and consistent lab operations.
Application and Benefits Optimized for routine research protocols, this solution is widely used to maintain aseptic conditions in cell culture workflows. It offers reliable performance in contamination-sensitive environments, helping researchers reduce the risk of microbial overgrowth without compromising cell health or experimental reproducibility. The sterile-filtered formulation eliminates the need for additional solubilization steps, supporting streamlined media preparation and reducing variability in daily lab procedures.
Usage and Compatibility To achieve standard working concentrations, dilute the solution 1:100 into your complete culture medium. The product is compatible with a broad range of mammalian cell lines and basal media. With consistent stock availability, researchers benefit from dependable supply continuity and simplified logistics planning. The solution should be stored at ≤ –15 °C and protected from repeated freeze-thaw cycles to maintain stability. For research use only. Not for use in diagnostic or therapeutic procedures. Not for use in humans or animals.CAD$62.10* -
Related products
Related products